Range
6.78 - 6.9
Vol / Avg.
6.2K/343.9K
Div / Yield
-
52 Wk
4.07 - 9.25
Mkt Cap
287M
Payout Ratio
-
Open
6.85
P/E
-
EPS
-6.98
Shares
42.1M
Outstanding
42.1M
Total Float
-
Sector: Health Care.Industry: Biotechnology
Taiwan Liposome Co Ltd is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products based on its proprietary drug delivery technologies. The company offers products in therapeutic areas, such as oncology, PAD, ophthalmology, fungal infection, arthritis, and anesthetic indications. Geographically, it derives a majority of revenue from China.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.140-0.080 0.0600
REV480.000K1.321M841.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
TLCTaiwan Liposome Co-4.7%287M

Taiwan Liposome Co Frequently Asked Questions

Q

How do I buy Taiwan Liposome Co (TLC) stock?

A

You can purchase shares of Taiwan Liposome Co (NASDAQ: TLC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Taiwan Liposome Co's (TLC) competitors?

Q

What is the target price for Taiwan Liposome Co (TLC) stock?

A

The latest price target for Taiwan Liposome Co (NASDAQ: TLC) was reported by HC Wainwright & Co. on July 13, 2021. The analyst firm set a price target for 7.50 expecting TLC to rise to within 12 months (a possible 9.96% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Taiwan Liposome Co (TLC)?

A

The stock price for Taiwan Liposome Co (NASDAQ: TLC) is $6.8209 last updated Today at 7:03:27 PM.

Q

Does Taiwan Liposome Co (TLC) pay a dividend?

A

There are no upcoming dividends for Taiwan Liposome Co.

Q

When is Taiwan Liposome Co (NASDAQ:TLC) reporting earnings?

A
Taiwan Liposome Co’s Q3 earnings are confirmed for after-market on October 27, 2021.
Q

Is Taiwan Liposome Co (TLC) going to split?

A

There is no upcoming split for Taiwan Liposome Co.

Q

What sector and industry does Taiwan Liposome Co (TLC) operate in?

A

Taiwan Liposome Co is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.